CN106619755A - Preparation method and preparation of natural moringa oleifera folic acid - Google Patents
Preparation method and preparation of natural moringa oleifera folic acid Download PDFInfo
- Publication number
- CN106619755A CN106619755A CN201611220581.5A CN201611220581A CN106619755A CN 106619755 A CN106619755 A CN 106619755A CN 201611220581 A CN201611220581 A CN 201611220581A CN 106619755 A CN106619755 A CN 106619755A
- Authority
- CN
- China
- Prior art keywords
- folic acid
- preparation
- natural
- moringa
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 161
- 235000019152 folic acid Nutrition 0.000 title claims abstract description 86
- 239000011724 folic acid Substances 0.000 title claims abstract description 86
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 229960000304 folic acid Drugs 0.000 title claims abstract description 75
- 235000011347 Moringa oleifera Nutrition 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 244000179886 Moringa oleifera Species 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 235000009508 confectionery Nutrition 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 244000288157 Passiflora edulis Species 0.000 claims abstract description 9
- 235000000370 Passiflora edulis Nutrition 0.000 claims abstract description 9
- 244000241838 Lycium barbarum Species 0.000 claims abstract 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract 2
- 241000220215 Moringa Species 0.000 claims description 35
- 238000000605 extraction Methods 0.000 claims description 26
- 239000012528 membrane Substances 0.000 claims description 24
- 244000241872 Lycium chinense Species 0.000 claims description 12
- 239000006286 aqueous extract Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 6
- 238000001471 micro-filtration Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 241000169546 Lycium ruthenicum Species 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001223 reverse osmosis Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims 5
- 241000372132 Hydrometridae Species 0.000 claims 1
- 235000002710 Ilex cornuta Nutrition 0.000 claims 1
- 241001310146 Ilex cornuta Species 0.000 claims 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 claims 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 235000013373 food additive Nutrition 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 2
- 229940105150 5-methyltetrahydrofolic acid Drugs 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 240000001238 Gaultheria procumbens Species 0.000 abstract 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 abstract 1
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 15
- 239000003826 tablet Substances 0.000 description 15
- 241001122767 Theaceae Species 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 229940014144 folate Drugs 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000686 essence Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- -1 tetrahydrofolic acid Chemical compound 0.000 description 6
- 239000007884 disintegrant Substances 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000576 food coloring agent Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- TZBGSHAFWLGWBO-ABLWVSNPSA-N (2s)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1h-pteridin-6-yl)methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CCC(=O)OC)C(O)=O)=CC=C1NCC1NC(C(=O)NC(N)=N2)=C2NC1 TZBGSHAFWLGWBO-ABLWVSNPSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- ZTVZLYBCZNMWCF-UHFFFAOYSA-N homocystine Chemical compound [O-]C(=O)C([NH3+])CCSSCCC([NH3+])C([O-])=O ZTVZLYBCZNMWCF-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002719 pyrimidine nucleotide Substances 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical group [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- AHRFRRASJMTTQU-UHFFFAOYSA-N 6-methyl-2,2-dioxooxathiazin-4-one;potassium Chemical compound [K].CC1=CC(=O)NS(=O)(=O)O1 AHRFRRASJMTTQU-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 description 1
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000009627 gardenia yellow Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003910 liver physiology Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- FCJSHPDYVMKCHI-UHFFFAOYSA-N phenyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OC1=CC=CC=C1 FCJSHPDYVMKCHI-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method and a preparation of natural moringa oleifera folic acid, belonging to the technical fields of food additives, nutrient health products and medicines. The natural moringa oleifera folic acid prepared by virtue of the preparation method is a composition containing tetrahydrofolic acid, 5-formyl tetrahydrofolic acid and 5-methyl tetrahydrofolic acid in a certain proportion; moringa oleifera leaf powder contains about 10 micrograms per gram of total natural folic acid, the content of the natural folic acid in a purified extract reaches up to 258 micrograms per gram without adding any organic reagent and enzyme by virtue of an optimized preparation method, and compared with the content of the natural folic acid in the raw materials, the content of the natural folic acid is increased by 25.8 times, so that the requirements on the content of folic acid in various health products, foods or additives in the current market; and besides, a passion fruit, sweet tea or wolfberry fruit water extract with natural antioxidant and preservation functions is added into the extracted raw materials, so that the chemical stability of a moringa oleifera folic acid extract is enhanced, and meanwhile, the content of the natural folic acid in the moringa oleifera folic acid extract is further increased.
Description
Technical field
The invention belongs to food additives, nutrient and healthcare products and pharmaceutical technology field, the natural leaf of more particularly to a kind of Moringa
The preparation method and preparation of acid.
Background technology
Moringa is a kind of torrid zone, subtropical plant, rich in various nutrition such as vegetable protein, vitamin, pantothenic acid, calcium, iron, selenium
Material, wherein, the content of protein is 2 times of milk, and the content of calcium is 4 times of milk, and ascorbic content is the 7 of orange
Times, the content of vitamin A is 4 times of carrot, and the content of iron is 3 times of spinach, and the content of potassium is 3 times of banana, gamma-amino
The content of butyric acid is 10 times of fermentation profound rice;Also contain natural folic acid, be 3-10 times of other fruits and vegetables, reach as high as 1100 μ g/
100g。
Folic acid belongs to B family vitamins, is to maintain a type organic necessary to organism normal living process, can help egg
White matter metabolism, and and Cobastab12Generation and the maturation of red blood cell are collectively promoted, is the indispensable material of manufacture red blood cell.Together
When folic acid also have antitumor, promote infant's nerve cell and brain cell development, treatment of vascular hardening and the effect blocked.Generation
Boundary's health organization is to the daily recommended amounts of folic acid:Adult's consumption is 400 μ g for the consumption of 200 μ g, pregnant woman and wet nurse;The U.S. pair
The daily recommended amounts of folic acid are:Adult's consumption is 400 μ g.
The important physiological action of folic acid is the carrier participation metabolism as one-carbon compound.The derivative tetrahydrofolic acid of folic acid
Carrier with co-enzyme form as one carbon unit (including formyl, formaldehyde and methyl), the transfer and formyl and formaldehyde to methyl
Utilization have important function.The biosynthesis of body adenylic acid, chest pyrimidine nucleotide, serine is mutual with glycine
Become, the biosynthesis of glutamic acid and choline, homocystine is converted into methionine and is required for tetrahydrofolic acid.Folic acid coenzyme promotes fast
Purine, the biosynthesis of chest pyrimidine nucleotide and methionine, serine, the conversion of glutamic acid, change, illustrate life of the folic acid in nucleic acid
Thing synthesizes the importance in the biosynthetic process with protein.This has also absolutely proved folic acid in cell growth and regeneration
Important function.
At present, the food addition folic acid and folic acid health products composition applied on market is all from synthesizing folic acid, synthesis
Folic acid is stable in properties, and synthetic route is ripe cheap, but compared with natural folic acid, tetrahydrochysene reductase is made in its metabolism palpus Jing liver
With can just be converted into the absorbable tetrahydrofolic acid for utilizing, Jing informal dresses increase liver physiology burden with easy.And tetrahydrochysene is also in human body
Protoenzyme lacks, and the effective bioavilability for synthesizing folic acid is relatively low, and long-term taking is also possible to that human body Zn-ef ficiency metabolic disorder can be caused,
The bad reaction of the organ such as skin, stomach is caused to occur, excessive use synthesis folic acid can also increase suffers from the diseases such as colon cancer, breast cancer
The risk of disease.The folic acid of natural origin is the reduction-state form structure of synthesis folic acid (including tetrahydrofolic acid, 5- methyl tetrahydrochysene leaves
Many glutamic acid substitution products of acid, 5- formoxyl tetrahydrofolic acids, 10- formoxyls tetrahydrofolic acid and tetrahydrofolic acid), its structure type
Determine that natural folic acid has more excellent bioavilability and security compared with synthesis folic acid.Therefore, research and develop a kind of natural
Folic acid becomes the technical problem of urgent need to resolve.
The content of the invention
The invention aims to overcome the deficiencies in the prior art, and provide a kind of preparation side of the natural folic acid of Moringa
Method, the natural folic acid of preparation method gained is safe and reliable, suitable long-term taking.
The object of the present invention is achieved like this, a kind of preparation method of the natural folic acid of Moringa, comprises the following steps:Take peppery
Wood, plus pure water extraction under conditions of temperature is for 20 DEG C~100 DEG C, filter, by filtrate concentrate drying.
Preferably, the Moringa includes the one kind in fresh leaf of Moringa, Moringa limb or leaf of Moringa powder, or they appoint
Meaning scalemic thereof;Every time the addition weight of the pure water is 10~80 times of the Moringa weight;The number of times of the extraction is 1
~4 times, the time extracted every time is 15~120 minutes;The mode of the extraction is carried out by the way of ultrasonic wave extraction;Institute
State drying is carried out using cryodesiccated mode.The plant capacity of ultrasonic wave extraction can be 500-3000 watt.
Preferably, while the ultrasonic wave extraction, when extracting mechanical agitation is carried out;During the filtration, first carry out
Centrifugation, gained supernatant is filtered again using the one kind in microfiltration membranes, milipore filter, NF membrane or reverse osmosis membrane.During centrifugation
Rotating speed can be 1000-5000 rev/min.
Preferably, the microfiltration membranes are filter membrane that aperture is 0.1~0.8 μm;The milipore filter is to allow 5~10 very much
The filter membrane that son amount is passed through;The NF membrane is to allow the filter membrane that the molecule of 300~1000 molecular weight is passed through.
Preferably, folic acid in make fresh leaf of Moringa is stablized, the fresh leaf of Moringa after plucking 12 hours with
Interior fresh leaf is preserved under conditions of being placed in -80 DEG C~0 DEG C.
Preferably, during described plus Aqua pure extract, adding the one kind in passion fruit, Sweet tea or Lycium chinense fruit aqueous extract, or hundred
Fragrant fruit, Sweet tea and Lycium chinense fruit aqueous extract mass ratio are 1:1:1 mixture.
Preferably, the addition weight of the passion fruit, Sweet tea or Lycium chinense fruit aqueous extract be the Moringa weight 3%~
8%;The Sweet tea is selected from frying Sweet tea;The fruit of Chinese wolfberry is selected from lycium ruthenicum.
Present invention also offers a kind of natural folic acid extract obtained by the preparation method, the natural folic acid extraction
Total folate content is 60 μ g/g~278 μ g/g in thing;Wherein, the natural folic acid dependency structure derivative content of contained certain proportion is most
Height is respectively:5- formoxyls tetrahydrofolic acid is 136 μ g/g, and methyl tetrahydrofolate is 50 μ g/g, and tetrahydrofolic acid is 92 μ g/g (numbers
According to the test from the products obtained therefrom of embodiment 10).
Present invention also offers a kind of preparation of natural folic acid extract, the preparation is oral formulations, injection, suppository
Or inhalant.When corresponding preparation is prepared, also including pharmaceutically acceptable auxiliary material.
Preferably, the oral formulations be tablet, capsule, granule, pulvis, microcapsules, pill, decoction, paste,
Dispersion powders, distillate medicinal water, oral liquid, pill or liposome.
Preferably, the injection is powder-injection or parenteral solution.
Preferably, the pharmaceutically acceptable accessory package contains Fruit powder, flavoring essence, sweetener, acid, filling
In agent, lubricant, preservative, suspending agent, food coloring, diluent, emulsifying agent, disintegrant or plasticizer one or two with
On mixture.
Preferably, Fruit powder is one or both of orange powder, orange powder, lemon powder, cherry powder, apple powder or coconut powder
Mixture above.But those skilled in the art think feasible Fruit powder within protection scope of the present invention, Fruit powder
Species is not limited thereto, and here of the present invention is not limited.
Preferably, flavoring essence is flavoring orange essence, orange essence, lemon extract, cherry essence, menthol, flavoring apple essence
Or mixture more than one or both of coconut essence.But those skilled in the art think feasible flavoring essence at this
Within bright protection domain, flavoring essence species is not limited thereto, and here of the present invention is not limited.
To increase the sugariness of medicine, it is easy to take.Preferably, sweetener is Sucralose, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt, Aspartame or sieve
Mixture more than one or both of sweet glycosides of Chinese fruit.But those skilled in the art think feasible sweetener in the present invention
Protection domain within, sweetener species is not limited thereto, and here of the present invention is not limited.
Preferably, acid is mixing more than one or both of citric acid, malic acid, lactic acid or citric acid
Thing.But those skilled in the art think feasible acid within protection scope of the present invention, acid species not office
It is limited to this, here of the present invention is not limited.
Filler refers to increase the weight and volume of tablet, beneficial to the auxiliary material of compressing tablet.Filler as tablet will
Ask mobility, compressibility good, adhesion is strong, there is larger saturation to medicine.Preferably, filler be fructose, glycitols,
Mixture more than one or both of sucrose, starch, pregelatinized starch, microcrystalline cellulose or dextrin.But art technology
Personnel think feasible disintegrant within protection scope of the present invention, and filler species is not limited thereto, and the present invention exists
This is not limited.
Lubricant refers to the auxiliary material that can reduce frictional force between tablet and die wall, to prevent frictional force big is stranded compressing tablet
Difficulty, pressure distribution is uniform when can make compressing tablet, and makes the even density of tablet, can also improve the outward appearance of tablet, makes tablet surface
It is bright, smooth.Preferably, lubricant is more than one or both of talcum powder, magnesium stearate, silica or stearic acid
Mixture.But those skilled in the art think feasible lubricant within protection scope of the present invention, lubricant species
It is not limited thereto, here of the present invention is not limited.
Preferably, preservative is Sodium Benzoate, Potassium Benzoate, sorbic acid methyl esters, ethyl-para-hydroxybenzoate or to hydroxyl
Mixture more than one or both of yl benzoic acid phenyl ester.But those skilled in the art think feasible preservative at this
Within the protection domain of invention, preservative species is not limited thereto, and here of the present invention is not limited.
Preferably, suspending agent is more than one or both of sodium carboxymethylcellulose, sodium alginate or beeswax mixed
Compound.But those skilled in the art think feasible suspending agent within protection scope of the present invention, and suspending agent species is not
This is confined to, here of the present invention is not limited.
Preferably, food coloring is more than one or both of caramel colorant, Gardenia Yellow, curcumin or chlorophyll
Mixture.But those skilled in the art think feasible food coloring within protection scope of the present invention, food coloring
Species is not limited thereto, and here of the present invention is not limited.
Preferably, diluent be edible vegetable oil, propane diols or molecular weight be in 400~6000 polyethylene glycol one
Mixture more than kind or both.But those skilled in the art think feasible diluent protection scope of the present invention it
Interior, diluent species is not limited thereto, and here of the present invention is not limited.
Preferably, emulsifying agent is S-40, stearoyl lactate/calcium, diacetyl tartarate monoglyceride, sucrose-fatty
Ester, molecular weight are mixture more than one or both of 400~6000 polyethylene glycol or distillation monoglyceride.But this area
Technical staff thinks feasible emulsifying agent within protection scope of the present invention, and emulsifier is not limited thereto, this
Bright here is not limited.
The Main Function of disintegrant is to eliminate the adhesion of tablet is formed because of adhesive or by pressurization to make tablet rapid
Disintegration, enables tablet to play drug effect rapidly.Preferably, disintegrant is dried starch, sodium carboxymethyl starch, low substituted hydroxy-propyl fibre
Mixture more than one or both of dimension element, PVPP or sodium carboxymethylcellulose.But this area skill
Art personnel think feasible disintegrant within protection scope of the present invention, and filler species is not limited thereto, the present invention
Here is not limited.
Preferably, plasticizer be glycerine, sodium carboxymethylcellulose, sorbierite or oleamide sodium sulfonate in one kind or
Mixture more than both.But those skilled in the art think feasible plasticizer within protection scope of the present invention, increase
Modeling agent species is not limited thereto, and here of the present invention is not limited.
Using above-mentioned technical proposal, due to directly obtaining natural folic acid, 5- formoxyls in the natural folic acid of gained from Moringa
, up to 136 μ g/g, up to 50 μ g/g, the content of tetrahydrofolic acid is up to 92 μ for the content of methyl tetrahydrofolate for the content of tetrahydrofolic acid
g/g.Compare synthesis folic acid, the natural folic acid of Moringa it is safe, toxic and side effect is little, can be taken for a long time.The present invention is also
There is provided the preparation method of the natural folic acid, and the preparation prepared by the natural folic acid.The preparation method is used at a certain temperature
Aqua pure extract, the method that gained active material is extracted apparently higher than prior art optimizes the composition of natural folic acid so that natural
Folic acid more easily absorption of human body simultaneously plays its physiological function.
Specific embodiment
The specific embodiment of the present invention is described further below.Here is it should be noted that for these enforcements
The explanation of mode is used to help understand the present invention, but does not constitute limitation of the invention.Additionally, invention described below
As long as involved technical characteristic does not constitute each other conflict and just can be mutually combined in each embodiment.
Embodiment 1
A kind of preparation method of the natural folic acid of Moringa, comprises the following steps:Leaf of Moringa powder is taken, plus pure water is 80 DEG C in temperature
Under conditions of extract, filter, filtrate is concentrated, freeze-drying.Wherein, the number of times of extraction is 1 time, and the time extracted every time is 30
Minute;Every time the addition weight of pure water is 20 times of the Moringa weight;The mode of extraction by the way of ultrasonic wave extraction come
Carry out;Drying is carried out using cryodesiccated mode.While ultrasonic wave extraction, when extracting mechanical agitation is carried out;Filter
When, first it is centrifuged, gained supernatant is carried out again using the one kind in microfiltration membranes, milipore filter, NF membrane or reverse osmosis membrane.Its
In, microfiltration membranes are filter membrane that aperture is 0.1~0.8 μm;The milipore filter is to allow the filter membrane that 5~100,000 molecular weight are passed through;Institute
It is to allow the filter membrane that the molecule of 300~1000 molecular weight is passed through to state NF membrane.
Embodiment 2-5
The temperature of extraction is changed to into respectively 20 DEG C, 40 DEG C, 60 DEG C or 100 DEG C by 80 DEG C, remaining preparation condition is pressed completely
Carry out according to the mode of embodiment 1, constitute embodiment 2-5.
The natural folate content testing result that embodiment 1-5 is obtained, is shown in Table 1.
Impact of the different Extracting temperatures of table 1 to natural folate content
Product | Extracting temperature | Natural folic acid |
Embodiment 1 | 80℃ | 208μg/g |
Embodiment 2 | 20℃ | 60μg/g |
Embodiment 3 | 40℃ | 115μg/g |
Embodiment 4 | 60℃ | 208μg/g |
Embodiment 5 | 100℃ | 160μg/g |
Embodiment 6-8
The number of times of extraction is changed to respectively 2 times, 3 times or 4 times by 1 time, remaining enters fully according to the mode of embodiment 1
OK, embodiment 6-8 is constituted.
The natural folate content testing result that embodiment 6-8 is obtained, is shown in Table 2.
Impact of the different extraction times of table 2 to natural folate content
Product | Extraction time | Natural folic acid |
Embodiment 6 | 2 | 163μg/g |
Embodiment 7 | 3 | 152μg/g |
Embodiment 8 | 4 | 135μg/g |
Embodiment 9-12
The time of extraction was changed to respectively 15 minutes, 60 minutes, 120 minutes or 180 minutes by 30 minutes, remaining is complete
Carry out according to the mode of embodiment 1, constitute embodiment 9-12.
The natural folate content testing result that embodiment 9-12 is obtained, is shown in Table 3.
Impact of the different extraction times of table 3 to natural folate content
Product | Extraction time | Natural folic acid |
Embodiment 9 | 15 minutes | 136μg/g |
Embodiment 10 | 60 minutes | 258μg/g |
Embodiment 11 | 120 minutes | 155μg/g |
Embodiment 12 | 180 minutes | 97μg/g |
Embodiment 13-15
The addition weight of each pure water is changed to into respectively 10 times, 40 times or 80 times by 20 times, remaining is fully according to enforcement
The mode of example 1 constitutes embodiment 13-15 carrying out.
The natural folate content testing result that embodiment 13-15 is obtained, is shown in Table 4.
Impact of the different extraction times of table 4 to natural folate content
Product | The addition weight of pure water | Natural folic acid |
Embodiment 13 | 10 times | 126μg/g |
Embodiment 14 | 40 times | 137μg/g |
Embodiment 15 | 80 times | 198μg/g |
Integrated embodiment 1-15, can show that the optimum condition extracted to the natural folic acid of Moringa is combined as:80 DEG C of Extracting temperature,
Extraction time 1 time, 60 minutes extraction times and Extraction solvent (pure water) addition are 20 times of weight.
Embodiment 16-19
Plus during Aqua pure extract, add the one kind in passion fruit, Sweet tea or Lycium chinense fruit aqueous extract, or passion fruit, Sweet tea with
Lycium chinense fruit aqueous extract mass ratio is 1:1:1 mixture.Wherein, the addition weight of passion fruit, Sweet tea or Lycium chinense fruit aqueous extract is
The 5% of the Moringa weight;The Sweet tea is selected from frying Sweet tea;The fruit of Chinese wolfberry is selected from lycium ruthenicum.Remaining is fully according to enforcement
The mode of example 1 constitutes embodiment 16-19 carrying out.
Embodiment 1, the natural folate content testing result that 16-19 is obtained, is shown in Table 5.
Table 5 adds impact of the different materials to natural folate content and shelf-life
From table 5, under identical extraction conditions, different materials are added, can be to the content of natural folic acid and its composition
There is significant impact, achieve unforeseeable technique effect.
In the present invention, frying Sweet tea just Sweet tea is placed in be stir-fried 45 minutes in the frying pan that temperature is 90 DEG C and obtains;The fruit of Chinese wolfberry
Water extract is to add 10 times of amount decoctings to boil 2 hours lycium ruthenicum, is filtered, and concentrate drying is obtained.
Embodiment 20
Natural folic acid product obtained by Example any one of 1-19, adds appropriate superfine silica gel powder, fills capsule, obtains final product glue
Wafer.
Embodiment 21
Natural folic acid product obtained by Example any one of 1-19, adds the appropriate orange powder of appropriate addition, orange essence, sucrose
Mix, compressing tablet obtains final product tablet.
Embodiment 22
Natural folic acid product obtained by Example any one of 1-19, adds suitable amount of sucrose powder, mixes, and granulation obtains particle
Agent.
Embodiment 23
Natural folic acid product obtained by Example any one of 1-19, adds water dissolves, adds appropriate Aspartame, Jiao
Fried sugar element, citric acid and Sodium Benzoate, mix, and filter, and bottling obtains oral solutions.
Embodiment 24
Natural folic acid product obtained by Example any one of 1-19, adds water for injection dissolving, adds appropriate amount of addition agent,
Routinely preparation method, makes injection.
Embodiment 25
Natural folic acid product obtained by Example any one of 1-19, adds appropriate amount of addition agent, and routinely preparation method, makes bolt
Agent.
Embodiment 26
Natural folic acid product obtained by Example any one of 1-19, adds appropriate amount of addition agent, and routinely preparation method, makes suction
Agent.
Embodiments of the present invention are explained in detail above, but the invention is not restricted to described embodiment.It is right
For those skilled in the art, in the case of without departing from the principle of the invention and spirit, these embodiments are carried out many
Plant change, modification, replace and modification, still fall within protection scope of the present invention.
Claims (9)
1. the preparation method of the natural folic acid of a kind of Moringa, it is characterised in that comprise the following steps:Moringa, plus pure water are taken in temperature
To extract under conditions of 20 DEG C~100 DEG C, filter, by filtrate concentrate drying.
2. the preparation method of the natural folic acid of a kind of Moringa according to claim 1, it is characterised in that the Moringa is comprising fresh
One kind in leaf of Moringa, Moringa limb or leaf of Moringa powder, or their arbitrary proportion mixture;The addition weight of each pure water
Measure as 10~80 times of the Moringa weight;The number of times of the extraction is 1~4 time, and the time extracted every time is 15~120 points
Clock;The mode of the extraction is carried out by the way of ultrasonic wave extraction;The drying is carried out using cryodesiccated mode.
3. the preparation method of the natural folic acid of a kind of Moringa according to claim 2, it is characterised in that the ultrasonic wave extraction
Meanwhile, carry out mechanical agitation when extracting;During the filtration, first it is centrifuged, gained supernatant adopts again microfiltration membranes, ultrafiltration
One kind in film, NF membrane or reverse osmosis membrane is filtered.
4. the preparation method of the natural folic acid of a kind of Moringa according to claim 3, it is characterised in that the microfiltration membranes are aperture
For 0.1~0.8 μm of filter membrane;The milipore filter is to allow the filter membrane that 5~100,000 molecular weight are passed through;The NF membrane is to allow
The filter membrane that the molecule of 300~1000 molecular weight is passed through.
5. a kind of preparation method of the natural folic acid of Moringa according to claim 1, it is characterised in that the fresh leaf of Moringa choosing
Fresh leaf from after harvesting within 12 hours is preserved under conditions of being placed in -80 DEG C~0 DEG C.
6. a kind of preparation method of the natural folic acid of Moringa according to claim 1, it is characterised in that described plus Aqua pure extract
When, add the one kind in passion fruit, Sweet tea or Lycium chinense fruit aqueous extract, or passion fruit, Sweet tea and Lycium chinense fruit aqueous extract mass ratio to be
1:1:1 mixture.
7. the preparation method of the natural folic acid of a kind of Moringa according to claim 6, it is characterised in that the passion fruit, Sweet tea
Or 3%~8% that the addition weight of Lycium chinense fruit aqueous extract is the Moringa weight;The Sweet tea is selected from frying Sweet tea;The Chinese holly
Matrimony vine is selected from lycium ruthenicum.
8. a kind of natural folic acid extract obtained based on preparation method described in any one of claim 1-7, the natural folic acid
The content of natural folic acid is 60 μ g/g~258 μ g/g in extract.
9. a kind of preparation comprising natural folic acid extract as claimed in claim 8, it is characterised in that the preparation is oral
Preparation, injection, suppository or inhalant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611220581.5A CN106619755A (en) | 2016-12-26 | 2016-12-26 | Preparation method and preparation of natural moringa oleifera folic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611220581.5A CN106619755A (en) | 2016-12-26 | 2016-12-26 | Preparation method and preparation of natural moringa oleifera folic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106619755A true CN106619755A (en) | 2017-05-10 |
Family
ID=58827514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611220581.5A Pending CN106619755A (en) | 2016-12-26 | 2016-12-26 | Preparation method and preparation of natural moringa oleifera folic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106619755A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113582996A (en) * | 2021-06-02 | 2021-11-02 | 韶关市星河生物科技有限公司 | Application of hypsizigus marmoreus strain in preparation of folic acid |
-
2016
- 2016-12-26 CN CN201611220581.5A patent/CN106619755A/en active Pending
Non-Patent Citations (1)
Title |
---|
R.K.SAINI等: "Relative bioavailability of folate from the traditional food plant Moringa oleifera L. as evaluated in a rat model", 《JOURNAL OF FOOD SCIENCE AND TECHNOLOGY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113582996A (en) * | 2021-06-02 | 2021-11-02 | 韶关市星河生物科技有限公司 | Application of hypsizigus marmoreus strain in preparation of folic acid |
CN113582996B (en) * | 2021-06-02 | 2024-02-06 | 韶关市星河生物科技有限公司 | Application of hypsizigus marmoreus strain in preparation of folic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018145664A1 (en) | Anti-fatigue composition for use in improving endurance performance | |
CN103864950B (en) | A kind of preparation method and applications of low molecule Porphyra haitanensis polysaccharide iron complexes | |
JP2013241354A (en) | Phosphodiesterase 2 inhibitor | |
JP6751709B2 (en) | Energy metabolism activator in muscle cells | |
CN103444974A (en) | Red jujube tablet candy and preparation method thereof | |
CN106455637A (en) | Chardonnay grape seed extract | |
CN103919920A (en) | Buccal tablet retaining original ecology of wolfberry fruits and preparation process thereof | |
CN114867863A (en) | Immobilization and stabilization method of nitrogen monoxide metabolome based on fermentation of nitrogen-containing natural substances | |
CN103385976A (en) | Applications of Pu'er tea or extracts thereof in anti-tumor | |
CN105999210A (en) | Lucid-ganoderma active lactobacillus preparation and preparing method | |
KR20160141027A (en) | Phamaceutical composition or healthy food comprising water extracts from Pleurotus eryngii var. ferulea (Pf.). for treating or preventing metabolic disorder | |
CN106619755A (en) | Preparation method and preparation of natural moringa oleifera folic acid | |
KR20150068959A (en) | Process for obtaining caffeoylquinic acids-rich extracts from helianthus annuus | |
CN105327332A (en) | Glutamine dipeptide oral tablet and preparation method thereof | |
CN103621871B (en) | Compound amino acid health-care product and preparation method thereof | |
JP6224899B2 (en) | Hypoglycemic agent | |
CN101884408A (en) | Ginkgo leaf leaching liquor and preparation method thereof | |
CN105495153A (en) | Antioxidant health-care product containing phycocyanin and ginkgo leaf extracts | |
CN105963330B (en) | Miracle fruit preparation and its application | |
KR20160026595A (en) | Composition for preventing or improving obesity and obesity-related disease comprising mixture of Coix lacryma-jobi L. var., Lentinus edodes, Poncirus trifoliata Rafin and Corn silk | |
JP6703685B1 (en) | Red blood cell depletion inhibitors, food additives and food and drink | |
CN110754666A (en) | Protein solid preparation and preparation method thereof | |
CN105454856A (en) | Health-care product capable of nourishing faces and replenishing blood | |
KR101360879B1 (en) | Composition containing extract of ribes diacanthum pall. for prevention and treatment of diabetes | |
JPWO2009107878A1 (en) | Vegetable extract containing adenine at high concentration, adenine-containing container-packed beverage containing the vegetable extract, oral antihypertensive composition comprising the vegetable extract as an active ingredient, and a method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |
|
RJ01 | Rejection of invention patent application after publication |